Penile Pyoderma Gangrenosum, a Rare Encounter in STI Healthcare: A Case Report and a Review of the Literature
DOI:
https://doi.org/10.2340/actadv.v104.32160Keywords:
penile disease, pyoderma gangrenosum, male genital diseasesAbstract
Abstract is missing (Short communication)
Downloads
References
Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol 2017; 18: 355-372.
https://doi.org/10.1007/s40257-017-0251-7 DOI: https://doi.org/10.1007/s40257-017-0251-7
Burian EA, Karlsmark T, Fogh K, Bech R. Pyoderma gangraenosum. Ugeskr Laeger 2021; 183: 1-10.
Al Ghazal P, Herberger K, Schaller J, Strölin A, Hoff N-P, Goerge T, et al. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. Orphanet J Rare Dis 2013; 8: 136.
https://doi.org/10.1186/1750-1172-8-136 DOI: https://doi.org/10.1186/1750-1172-8-136
Jockenhöfer F, Wollina U, Salva KA, Benson S, Dissemond J. The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum. Br J Dermatol 2019; 180: 615-620.
https://doi.org/10.1111/bjd.16401 DOI: https://doi.org/10.1111/bjd.16401
Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, et al. Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi Consensus of International Experts. JAMA Dermatol 2018; 154: 461-466.
https://doi.org/10.1001/jamadermatol.2017.5980 DOI: https://doi.org/10.1001/jamadermatol.2017.5980
Tolkachjov SN, Fahy AS, Cerci FB, Wetter DA, Cha SS, Camilleri MJ. Postoperative pyoderma gangrenosum: a clinical review of published cases. Mayo Clin Proc 2016; 91: 1267-1279.
https://doi.org/10.1016/j.mayocp.2016.05.001 DOI: https://doi.org/10.1016/j.mayocp.2016.05.001
Brooklyn TN, Dunnill MGS, Shetty A, Bowden JJ, Williams JDL, Griffiths CEM, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006; 55: 505-509.
https://doi.org/10.1136/gut.2005.074815 DOI: https://doi.org/10.1136/gut.2005.074815
Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, et al. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ 2015; 350: h2958.
https://doi.org/10.1136/bmj.h2958 DOI: https://doi.org/10.1136/bmj.h2958
Partridge ACR, Bai JW, Rosen CF, Walsh SR, Gulliver WP, Fleming P. Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials. Br J Dermatol 2018; 179: 290-295.
https://doi.org/10.1111/bjd.16485 DOI: https://doi.org/10.1111/bjd.16485
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Kirsten Salado-Rasmussen, Kasper Køhler Alsing, Nina Løth Mårtensson, Ewa Anna Burian, Helle Kiellberg Larsen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.